A Singular Role of I Promoting the Development of Cardiac Automaticity During Cardiomyocyte Differentiation by I -Induced Activation of Pacemaker Current
Overview
Authors
Affiliations
The inward rectifier potassium current (I) is generally thought to suppress cardiac automaticity by hyperpolarizing membrane potential (MP). We recently observed that I could promote the spontaneously-firing automaticity induced by upregulation of pacemaker funny current (I) in adult ventricular cardiomyocytes (CMs). However, the intriguing ability of I to activate I and thereby promote automaticity has not been explored. In this study, we combined mathematical and experimental assays and found that only I and I, at a proper-ratio of densities, were sufficient to generate rhythmic MP-oscillations even in unexcitable cells (i.e. HEK293T cells and undifferentiated mouse embryonic stem cells [ESCs]). We termed this effect I-induced I activation. Consistent with previous findings, our electrophysiological recordings observed that around 50% of mouse (m) and human (h) ESC-differentiated CMs could spontaneously fire action potentials (APs). We found that spontaneously-firing ESC-CMs displayed more hyperpolarized maximum diastolic potential and more outward I current than quiescent-yet-excitable m/hESC-CMs. Rather than classical depolarization pacing, quiescent mESC-CMs were able to fire APs spontaneously with an electrode-injected small outward-current that hyperpolarizes MP. The automaticity to spontaneously fire APs was also promoted in quiescent hESC-CMs by an I-specific agonist zacopride. In addition, we found that the number of spontaneously-firing m/hESC-CMs was significantly decreased when I was acutely upregulated by Ad-CGI-HCN infection. Our study reveals a novel role of I promoting the development of cardiac automaticity in m/hESC-CMs through a mechanism of I-induced I activation and demonstrates a synergistic interaction between I and I that regulates cardiac automaticity.
Zacopride stimulates 5-HT serotonin receptors in the human atrium.
Neumann J, Hesse C, Hofmann B, Gergs U Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6821-6835.
PMID: 38557827 PMC: 11422277. DOI: 10.1007/s00210-024-03051-5.
Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy.
Marchiano S, Nakamura K, Reinecke H, Neidig L, Lai M, Kadota S Cell Stem Cell. 2023; 30(4):396-414.e9.
PMID: 37028405 PMC: 10283080. DOI: 10.1016/j.stem.2023.03.010.
Seibertz F, Sutanto H, Dulk R, Pronto J, Springer R, Rapedius M Basic Res Cardiol. 2023; 118(1):14.
PMID: 37020075 PMC: 10076390. DOI: 10.1007/s00395-022-00973-0.
Graft-host coupling changes can lead to engraftment arrhythmia: a computational study.
Gibbs C, Marchiano S, Zhang K, Yang X, Murry C, Boyle P J Physiol. 2023; 601(13):2733-2749.
PMID: 37014103 PMC: 10901678. DOI: 10.1113/JP284244.
Diversity of cells and signals in the cardiovascular system.
Grandi E, Navedo M, Saucerman J, Bers D, Chiamvimonvat N, Dixon R J Physiol. 2023; 601(13):2547-2592.
PMID: 36744541 PMC: 10313794. DOI: 10.1113/JP284011.